Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Cash from Financing Activities: 2021-2025

Historic Cash from Financing Activities for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to -$5.3 million.

  • Core Scientific's Cash from Financing Activities fell 102.92% to -$5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $556.9 million, marking a year-over-year increase of 174.19%. This contributed to the annual value of $819.6 million for FY2024, which is 1935.58% up from last year.
  • As of Q3 2025, Core Scientific's Cash from Financing Activities stood at -$5.3 million, which was up 83.24% from -$31.8 million recorded in Q2 2025.
  • Core Scientific's Cash from Financing Activities' 5-year high stood at $598.2 million during Q4 2024, with a 5-year trough of -$45.1 million in Q3 2022.
  • Over the past 3 years, Core Scientific's median Cash from Financing Activities value was -$5.3 million (recorded in 2025), while the average stood at $66.7 million.
  • As far as peak fluctuations go, Core Scientific's Cash from Financing Activities crashed by 148.04% in 2023, and later skyrocketed by 5,424.49% in 2024.
  • Over the past 5 years, Core Scientific's Cash from Financing Activities (Quarterly) stood at $170.2 million in 2021, then slumped by 77.63% to $38.1 million in 2022, then tumbled by 148.04% to -$18.3 million in 2023, then surged by 3,369.23% to $598.2 million in 2024, then plummeted by 102.92% to -$5.3 million in 2025.
  • Its Cash from Financing Activities was -$5.3 million in Q3 2025, compared to -$31.8 million in Q2 2025 and -$4.2 million in Q1 2025.